The US Department of Health and Human Services (HHS) has released final guidance for the second cycle of Medicare drug price negotiations. 3 October 2024
The Russian government has finalized the rules for granting preference to domestic drugs in public procurements, which will come into force in 2025. 1 October 2024
The Danish government is to remove the rules that currently prohibit the purchase of medicines from countries outside the European Union (EU) in a move that has not been welcomed by pharma. 30 September 2024
India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. 30 September 2024
Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR). 30 September 2024
The generics and biosimilars trade group, Medicines for Europe, has put out a strong message amid ongoing discussions on a European Union (EU) Critical Medicines Act. 26 September 2024
US biotech Emergent BioSolutions revealed it has secured approximately $400 million in orders in 2024 and 2025 associated with its vaccinia, smallpox and mpox product portfolio. 26 September 2024
The UK government has released a position paper outlining its vision for Framework Programme 10 (FP10), a successor to Horizon Europe, the EU's flagship research collaboration program. 26 September 2024
President Biden has said the USA will commit at least $500 million to support African countries in battling the ongoing mpox outbreak in Central and Eastern Africa. 25 September 2024
The Pharmaceutical Research and Manufacturers of America (PhRMA) is continuing its legal challenge against the US government’s drug pricing reforms. 24 September 2024
The Foundation for Economic and Industrial Research and Greek pharma trade group the Hellenic Association of Pharmaceutical Companies have presented two studies reflecting the industry’s importance. 23 September 2024
Basilea Pharmaceutica announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) has awarded Basilea an Other Transaction Agreement (OTA), under OTA number 75A50124C00033. 20 September 2024
Novo Nordisk is under increasing pressure over the cost of its blockbuster drugs in the USA, as chief executive Lars Fruergaard Jørgensen prepares to testify before a powerful Senate committee. 18 September 2024
The research based pharmaceutical industry has welcomed Mario Draghi’s report, published by the European Commission, outlining proposals on how Europe can regain its competitive edge and the critical role of innovative industries in achieving this. 11 September 2024
Even as emerging signs of a thaw in the broader Indian start-up funding landscape were evident, the Competition Commission of India (CCI) has tightened its exemption list under new combination rules. 11 September 2024
The US House of Representatives has passed the BIOSECURE Act, gaining bipartisan support with a vote of 306–81. Nearly all of the votes against the bill came from Democrats. 10 September 2024
The Cell and Gene Therapy Catapult (CGT Catapult) has highlighted what it regards as the UK's potential to lead the global cell and gene therapy sector. 5 September 2024
The budget on October 30 is an opportunity to end short-termism, cut waste, and attract long-term investment to the country’s economy with a sector-targeted R&D tax relief policy, according to the UK BioIndustry Association (BIA). 3 September 2024
The Danish Pharmaceutical Industry Association, Lif, has given its verdict on the government financial bill setting out new priorities in health in 2025. 2 September 2024
Marseille-based ImCheck Therapeutics has received 20.2 million euros ($22.4 million) in non-dilutive funding as part of the i-Démo call for projects under the France 2030 Plan operated by Bpifrance on behalf of the French government. 29 August 2024
The issue of US drug pricing and what government action might be taken to lower prices are getting as many headlines as ever at the start of 2019, but China is currently providing more striking evidence of action on cutting drugmakers’ margins. 3 January 2019
The Community Oncology Alliance (COA) recently submitted formal comments to the Centers for Medicare and Medicaid Services (CMS) regarding the Medicare Program International Pricing Index Model for Medicare Part B Drugs pre-proposed rule, also known as the IPI Model. 3 January 2019
The Russian government has expanded the list of vital and essential drugs from 699 to 735 items for 2019, according to recent statements by the press-service of Russia’s Prime Minister Dmitry Medvedev, reports The Pharma Letter’s local correspondent. 26 December 2018
Russia’s pharmaceutical industry professional associations last week called for maintaining the technical conditions for implementing the project for monitoring the movement of medicines within the framework of the requirements developed earlier in the pilot project. 24 December 2018
The US Department of Justice obtained more than $2.8 billion in settlements and judgments from civil cases involving fraud and false claims against the government in the fiscal year ending September 30, 2018, it was announced on Friday. 24 December 2018
China, with its reformed priority review and approval processes, is supporting biotech revolution in the country and thereby allowing domestic drug developers to compete with well-established multinational counterparts. 21 December 2018
Pharma trade group Medicines Australia has welcomed today’s Mid-Year Economic and Fiscal Outlook (MYEFO), announced by Treasurer Josh Frydenberg. 17 December 2018
The Russian government has adopted a new method for determining the prices for vital and essential drugs, according to an official spokesman of Russian Minister of Health Veronika Skvortsova, reports The Pharma Letter’s local correspondent. 13 December 2018
The World Health Organization (WHO) says that Tanzania has become the first country in Africa to achieve a “well-functioning regulatory system for medical products.” 12 December 2018
The US House of Representatives has approved a bill that would prevent drugmakers from overcharging Medicaid in the way Mylan (Nasdaq: MYL) was famously accused of doing. 12 December 2018
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has named David Ricks, the chairman and chief executive of US pharma major Eli Lilly, as its new president. 11 December 2018
Just head of UK Prime Minister Theresa May’s decision was announced to postpone the parliamentary vote on the Brexit withdrawal declaration that was due on Tuesday, the European Federation of Pharmaceutical Industries and Associations (EFPIA) today issued another warning about the implications for the pharma industry. 10 December 2018
The Greek pharmaceutical industry has reached its limits due to a number of “unreasonable” burdens imposed by the government during the crisis, Olympios Papadimitriou, president of the Hellenic Association of Pharmaceutical Companies (SFEE) and general manager of Novo Nordisk in Greece, told EURACTIV.com in an interview that is posted on the trade group’s website. 10 December 2018
The well-documented case of Medicaid being overcharged over EpiPen (epinephrine), the emergency allergy treatment from Mylan, has led two Senators to propose a bipartisan bill. 5 December 2018
Today the UK government has published the second Life Sciences Sector Deal, the extension of a previous set of deals announced alongside the UK’s Industrial Strategy in November 2017. 5 December 2018
A coalition of 55 Conservative groups and activists have voiced major concerns at President Donald Trump’s proposals on Medicare drug prices. 29 November 2018
At a time when the sector is engulfed in Brexit uncertainty, some rare good news has been announced for drugmakers and patients in the UK. 23 November 2018
Indonesia's National Agency for Drug and Food Control (BPOM) held the First Meeting of the Heads of National Medicines Regulatory Authorities (NMRAs) from the Organization of Islamic Cooperation (OIC) member states in Jakarta, on November 21-22. 23 November 2018
The UK government-backed Cell and Gene Therapy Catapult (CGT Catapult) has launched a new apprenticeship program aimed at supporting the development of Advanced Therapy Medicinal Products (ATMP). 23 November 2018
A sub-committee in the UK House of Lords has written to the Health Secretary requesting information on what plans are in place to ensure continued access to medicines in the event of a so-called “no deal” Brexit. 22 November 2018